INCY Incyte Corporation

Price (delayed)

$90.49

Market cap

$19.79B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.89

Enterprise value

$18.51B

Sector: Healthcare
Industry: Biotechnology
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib). The company was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.

Highlights

INCY's equity is up by 21% since the previous quarter and by 4.3% year-on-year
Incyte's revenue has increased by 19% YoY and by 7% from the previous quarter
INCY's net income has dropped by 162% year-on-year but it is up by 49% since the previous quarter
INCY's EPS has shrunk by 162% YoY but it is up by 49% QoQ
The debt is up by 2.8% year-on-year

Key stats

What are the main financial stats of INCY
Market
Shares outstanding
218.7M
Market cap
$19.79B
Enterprise value
$18.51B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
8.39
Price to sales (P/S)
8.25
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.75
Earnings
Revenue
$2.39B
EBIT
-$120.38M
EBITDA
-$67.48M
Free cash flow
-$107.63M
Per share
EPS
-$0.89
Free cash flow per share
-$0.49
Book value per share
$10.79
Revenue per share
$10.97
TBVPS
$13.21
Balance sheet
Total assets
$3.21B
Total liabilities
$867.72M
Debt
$51.69M
Equity
$2.34B
Working capital
$1.52B
Liquidity
Debt to equity
0.02
Current ratio
3.73
Quick ratio
3.62
Net debt/EBITDA
18.93
Margins
EBITDA margin
-2.8%
Gross margin
94.9%
Net margin
-8%
Operating margin
-7.7%
Efficiency
Return on assets
-6.1%
Return on equity
-8.2%
Return on invested capital
-13.8%
Return on capital employed
-4.5%
Return on sales
-5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

INCY stock price

How has the Incyte stock price performed over time

Financial performance

How have Incyte's revenue and profit performed over time
Revenue
$2.39B
Gross profit
$2.26B
Operating income
-$184.82M
Net income
-$191.07M
Gross margin
94.9%
Net margin
-8%
INCY's net income has dropped by 162% year-on-year but it is up by 49% since the previous quarter
Incyte's operating income has plunged by 159% YoY but it has increased by 42% from the previous quarter
The net margin has dropped by 153% year-on-year but it has soared by 53% since the previous quarter
INCY's operating margin has dropped by 150% year-on-year but it is up by 46% since the previous quarter

Growth

What is Incyte's growth rate over time

Valuation

What is Incyte stock price valuation
P/E
N/A
P/B
8.39
P/S
8.25
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.75
INCY's EPS has shrunk by 162% YoY but it is up by 49% QoQ
The stock's price to book (P/B) is 67% less than its 5-year quarterly average of 25.3 but 6% more than its last 4 quarters average of 7.9
INCY's equity is up by 21% since the previous quarter and by 4.3% year-on-year
INCY's P/S is 37% below its 5-year quarterly average of 13.1
Incyte's revenue has increased by 19% YoY and by 7% from the previous quarter

Efficiency

How efficient is Incyte business performance
INCY's return on assets has dropped by 154% year-on-year but it has surged by 50% since the previous quarter
The ROE has plunged by 154% YoY but it has grown by 50% from the previous quarter
The ROIC has plunged by 132% YoY but it has soared by 64% from the previous quarter
INCY's ROS has shrunk by 132% YoY but it has soared by 65% QoQ

Dividends

What is INCY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INCY.

Financial health

How did Incyte financials performed over time
The company's quick ratio fell by 34% YoY but it rose by 10% QoQ
The current ratio has contracted by 34% YoY but it has grown by 9% from the previous quarter
The debt is 98% smaller than the equity
INCY's equity is up by 21% since the previous quarter and by 4.3% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.